Business Description
![Titan Pharmaceuticals Inc Titan Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C00000CNT.png?14)
Titan Pharmaceuticals Inc
NAICS : 325414
SIC : 2836
ISIN : US8883143096
Description
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 186.64 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -78.91 | |||||
Beneish M-Score | 881.24 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -92.9 | |||||
3-Year EBITDA Growth Rate | 36.6 | |||||
3-Year EPS without NRI Growth Rate | 34 | |||||
3-Year FCF Growth Rate | 53.5 | |||||
3-Year Book Growth Rate | -4.9 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 16.16 | |||||
9-Day RSI | 24.82 | |||||
14-Day RSI | 30.17 | |||||
6-1 Month Momentum % | -21.64 | |||||
12-1 Month Momentum % | -50.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.83 | |||||
Quick Ratio | 11.83 | |||||
Cash Ratio | 11.02 | |||||
Days Sales Outstanding | 16279 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -29.8 | |||||
Shareholder Yield % | -2.66 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -664300 | |||||
Net Margin % | -495400 | |||||
FCF Margin % | -580600 | |||||
ROE % | -126.92 | |||||
ROA % | -89.39 | |||||
ROIC % | -1051.44 | |||||
ROC (Joel Greenblatt) % | -4950.07 | |||||
ROCE % | -169.91 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5390 | |||||
PB Ratio | 0.81 | |||||
Price-to-Tangible-Book | 0.81 | |||||
EV-to-EBIT | 0.19 | |||||
EV-to-EBITDA | 0.19 | |||||
EV-to-Revenue | -1270 | |||||
EV-to-Forward-Revenue | 68.41 | |||||
EV-to-FCF | 0.22 | |||||
Price-to-Net-Current-Asset-Value | 0.81 | |||||
Price-to-Net-Cash | 0.88 | |||||
Earnings Yield (Greenblatt) % | 526.32 | |||||
FCF Yield % | -117.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TTNP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Titan Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.001 | ||
EPS (TTM) ($) | -6.45 | ||
Beta | 1.42 | ||
Volatility % | 57.22 | ||
14-Day RSI | 30.17 | ||
14-Day ATR ($) | 0.398132 | ||
20-Day SMA ($) | 6.489115 | ||
12-1 Month Momentum % | -50.34 | ||
52-Week Range ($) | 5 - 13.968 | ||
Shares Outstanding (Mil) | 0.91 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Titan Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Titan Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Titan Pharmaceuticals Inc Frequently Asked Questions
What is Titan Pharmaceuticals Inc(TTNP)'s stock price today?
The current price of TTNP is $5.39. The 52 week high of TTNP is $13.97 and 52 week low is $5.00.
When is next earnings date of Titan Pharmaceuticals Inc(TTNP)?
The next earnings date of Titan Pharmaceuticals Inc(TTNP) is 2024-08-14 Est..
Does Titan Pharmaceuticals Inc(TTNP) pay dividends? If so, how much?
Titan Pharmaceuticals Inc(TTNP) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |